Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • matt.berry01 matt.berry01 Dec 18, 2013 10:52 AM Flag

    AEGR's serious competition and exclusions

    ISIS' Kynamro, ongoing anti-PCSK9 trials, gastrointestinal problems & fatty liver disease dropouts, statin interaction, exclusion of those under 18 yrs old, high cost, etc... will carve up AEGR's very very small pie into a very small slice. Note that besides the threat of anti-PCSK9 approval, the anti-PCSK TRIALS alone threaten AEGR market share ... and AMGN is recruiting as we speak.

    Matt
    - 3footcrowbar

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AEGR
17.76+0.06(+0.34%)Aug 27 4:00 PMEDT